<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02792270</url>
  </required_header>
  <id_info>
    <org_study_id>15-485</org_study_id>
    <nct_id>NCT02792270</nct_id>
  </id_info>
  <brief_title>Effects Of Caloric Restriction On Post-Operative Complications In Sarcoma Patients Treated With Pre-Operative Radiation Therapy</brief_title>
  <official_title>Effects Of Caloric Restriction On Post-Operative Complications In Sarcoma Patients Treated With Pre-Operative Radiation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NORCH (Nutrition Obesity Research Center at Harvard)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to decrease the rate of surgical wound complications. The
      investigators are studying the effects that caloric restriction has on decreasing the rate of
      surgical wound complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal is to decrease the chance of having wound complications after surgery. Caloric
      Restriction has been found to be a natural modifier of surgical outcomes. Participants will
      be randomize into the arms Caloric Restriction Diet or Normal Diet.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change In The Rate Of Physical Function</measure>
    <time_frame>Baseline, 6 weeks, 3 months and 6 months visits after surgery</time_frame>
    <description>Musculoskeletal Tumor Society Rating Scale (MSTS, a clinician-rated scale scoring)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change In The Rate Of Physical Function</measure>
    <time_frame>Baseline, 6 weeks, 3 months and 6 months visits after surgery</time_frame>
    <description>Toronto Extremity Salvage Score (TESS, a patient reported questionnaire scoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Rate Of Wound Healing</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Rate Of Wound Complications In The Protein Caloric Restriction (PCR) Versus Control Group</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Tumor Surgery</condition>
  <arm_group>
    <arm_group_label>Caloric Restriction Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will meet with the Registered Dietitian to discuss calorie, protein and fluid needs.The dietitian will calculate calorie needs.
Calorie needs will then be reduced to 30%.
Protein needs will be estimated based on 0.8g/kg BW and then reduced by 70%.
Dietitian will educate participants on electrolytes and fluid intake based on the reduced food intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participant will follow a normal diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Caloric Restriction Diet</intervention_name>
    <description>A nutritional supplement called Scandishake (Nutridrinks, Perivale, UK) will be used for 3 days before surgery.
- Scandishake will be mixed with 8 oz of whole fat cow milk, whole fat lactaid milk, almond milk or soy milk. The proposed macronutrient profile for the 3 days of caloric restriction (CR) is: 45% fat, 46% carbohydrate, and 8% protein.</description>
    <arm_group_label>Caloric Restriction Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years

          -  Biopsy proven soft tissue sarcoma located in the extremities

          -  Patient to be treated with radiation therapy for a primary extremity soft tissue
             sarcoma or recurrent tumor after surgery, followed by surgical resection

          -  Karnofsky Score ≥ 60%

          -  Body Mass Index (BMI) ≥ 20 kg/m2

          -  Albumin and pre-albumin levels within normal limits

        Exclusion Criteria:

          -  Current pregnancy and breast feeding

          -  Other cancers diagnosed within the last 5 years (in situ and/or invasive)

          -  Diabetes mellitus

          -  Current metformin therapy

          -  Other conditions may exclude participants from the study (e.g. intractable
             nausea/emesis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen De Amorin Bernstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karen De Amorin Bernstein, MD</last_name>
    <phone>617-726-6876</phone>
    <email>kbernstein@mgh.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts general Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karen De Amorin Bernstein, MD</last_name>
      <phone>617-726-6876</phone>
      <email>kbernstein@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Karen De Amorin Bernstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2016</study_first_submitted>
  <study_first_submitted_qc>June 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2016</study_first_posted>
  <last_update_submitted>June 1, 2016</last_update_submitted>
  <last_update_submitted_qc>June 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Karen De Amorim Bernstein, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

